Here’s Analysts’ Take On Dr. Reddy’s Q2 Earnings
Bottles of Reditux are arranged for a picture in one of Dr. Reddy’s Laboratories Ltd. bio-tech labs outside of Hyderabad. (Photographer: Scott Eells/Bloomberg News)

Here’s Analysts’ Take On Dr. Reddy’s Q2 Earnings

Dr Reddy’s Laboratories Ltd.’s second-quarter profit more than doubled beating estimates on a one-time tax write-back and a licensing fee.The drugmaker wrote back Rs 326-crore tax and received a li...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.